GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » T&R Biofab Co Ltd (XKRX:246710) » Definitions » COGS-to-Revenue

T&R Biofab Co (XKRX:246710) COGS-to-Revenue : 0.84 (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is T&R Biofab Co COGS-to-Revenue?

T&R Biofab Co's Cost of Goods Sold for the three months ended in Mar. 2025 was ₩4,977 Mil. Its Revenue for the three months ended in Mar. 2025 was ₩5,955 Mil.

T&R Biofab Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.84.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. T&R Biofab Co's Gross Margin % for the three months ended in Mar. 2025 was 16.43%.


T&R Biofab Co COGS-to-Revenue Historical Data

The historical data trend for T&R Biofab Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T&R Biofab Co COGS-to-Revenue Chart

T&R Biofab Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 1.07 0.73 0.79 0.56

T&R Biofab Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.45 0.65 0.73 0.84

T&R Biofab Co COGS-to-Revenue Calculation

T&R Biofab Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=2741.791 / 4873.728
=0.56

T&R Biofab Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=4976.657 / 5955.257
=0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


T&R Biofab Co  (XKRX:246710) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

T&R Biofab Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 4976.657 / 5955.257
=16.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


T&R Biofab Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of T&R Biofab Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


T&R Biofab Co Business Description

Traded in Other Exchanges
N/A
Address
Sangidaehak-ro 237, Gyeonggi-do, Siheung-si, KOR, 540
T&R Biofab Co Ltd is a Korea based biomedical engineering company. It is mainly engaged in manufacturing bioresorbable scaffolds that aids in regeneration and reconstruction of tissues and organs using innovative 3D printing technology.

T&R Biofab Co Headlines

No Headlines